
Riadh Daghfous
Riadh Daghfous is the Director General of the National Center for Pharmacological Vigilance in Tunisia. Recently, he was in the news for reassuring the public that the new Covid-19 variant, Nimbus, does not pose a significant threat to the country, citing strong immunity among the population from prior infections and vaccination campaigns. He emphasized that the current epidemiological situation in Tunisia remains stable, with very few Covid-19 cases reported, while also warning about the risks posed by seasonal viruses, particularly to vulnerable populations.
Not in the pool (under ¢1).
Recent news mentions
Dr. Riadh Daghfous is the President of the Tunisian Association of Pharmacology who outlined the congress's main points.
Ministre de la Santé: « Bientôt une loi sur les compléments alimentaires »
Dr. Riadh Daghfous is the President of the Tunisian Association of Pharmacology who addressed the congress's main points.
« Bientôt une loi sur les compléments alimentaires » – La Presse de Tunisie
Dr Riadh Daghfous affirmed that the new sub-variant of COVID-19, named 'Nimbus', does not pose a serious threat to public health.
Faut-il s’inquiéter du variant ‘Nimbus’ en Tunisie ? – La Presse de Tunisie
Riadh Daghfous is the director general of the National Center for Pharmacovigilance in Tunisia.
Quel danger pour la Tunisie ? – La Presse de Tunisie